Eddie Hickman

Stock Analyst at Guggenheim

(3.68)

# 695

Out of 4,667 analysts

6

Total ratings

66.67%

Success rate

40.89%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Eddie Hickman

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	OTLK Outlook Therapeutics	Upgrades: Buy	$40	$5.28	+657.58%	2	Jan 25, 2024
	TARS Tarsus Pharmaceuticals	Maintains: Buy	$46 → $49	$46.58	+5.20%	4	Sep 11, 2023

Outlook Therapeutics

Jan 25, 2024

Upgrades: Buy

Price Target: $40

Current: $5.28

Upside: +657.58%

Tarsus Pharmaceuticals

Sep 11, 2023

Maintains: Buy

Price Target: $46 → $49

Current: $46.58

Upside: +5.20%